ABSTRACf. Preobese fetuses have elevated thyroid hormone levels and depressed growth hormone levels relative to lean fetuses. Therefore, we are studying various experimental fetal pig models to explore the relationship between endocrine status and onset of obesity. In the present study, intact and hypophysectomized (d 70) fetuses were implanted with thyroxine (T 4 ) pellets on d 70 of gestation, and blood, adipose tissue, and skin samples were obtained upon removal of d 90 of gestation. Body weights were similar for all groups and T 4 treatment reversed myxedema in hypophysectomized fetuses. Serum T4 levels were elevated (p < 0.05) and skin and hair development were enhanced (p < 0.05) to a similar degree by T4 treatment in intact and hypophysectomized fetuses. However, T4 did not influence adipose tissue development in intact fetuses, but markedly enhanced development in hypophysectomized fetuses. For instance, fat cell size and lipogenic enzyme activities in hypophysectomized fetuses were increased (p < 0.05) by 5-mg and 15-mg T4 treatments, with a marked increase (p < 0.05) in apparent fat cell number with the 15-mg T4 treatment. In contrast, there was no effect of T4 (15 mg) on these parameters in intact fetuses. Therefore, fetal obesity may be directly associated with elevated thyroid hormone levels and suppressed growth hormone levels, but not with elevated Tz levels alone. (Pediatr Res 32: 204-211,1992) Abbreviations hypox, hyphophysectomy/hypophysectomized GH, growth hormone T4, thyroxine LPL, lipoprotein lipase G6PDH, glucose-6-phosphate dehydrogenase CV, coefficient of variation AGV, average gray values T 3 , triiodothyronine near term , fat cell size and lipogenic enzyme activity were also increased by fetal hypox on d 70, but hypox significantly reduced fat cell number (4). Furthermore, fat cell number, size, and lipogenic activity were elevated in fetuses obtained from dams made diabetic with alloxan (5). Consideration of the fetal endocrine profiles in these studies indicated that GH levels were negatively correlated and thyroid hormone levels positively correlated with fat cell development (for review see Refs. 1 and 2). These correlations are strongly supported by results of preadipocyte studies in primary cultures (for review see Refs. 1 and 2). For instance, serum from hypox fetuses produced less preadipocyte proliferation but more differentiation than did serum from control (intact) fetuses when tested on primary cultures of rat preadipocytes (6). Supplementing serum from hypox fetuses with T4 to levels present in control fetuses enhanced its capacity to stimulate rat preadipocyte replication and differentiation in primary cultures (6). Furthermore, normalizing (supplementation) GH levels in serum from hypox fetuses reduced its capacity to induce differentiation , but had no effect on the capacity to stimulate proliferation in vitro (6). Similar roles for T4 and GH in preadipocyte development were demonstrated in studies of serum-free cultures of pig cells (7, 8) .
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Therefore, direct (in vitro) and indirect evidence suggests a definitive role for T4 and GH in fetal adipocyte development. However, the singular influence of T4 and/or GH on fetal adipocyte development in vivo has not been examined. Therefore, one objective of the present study was to examine adipose tissue development in hypox (ablated d 70) fetuses after normalization of T4 levels by implanting slow release (21 d) T4 pellets. Because 70-d pig fetuses have very low levelsof thyroid hormones (9, 10), we also implanted T4 pellets in intact (control) 70-d fetuses. Therefore, another objective of this study was to compare the influence of T4 on adipose tissue development in intact and hypox fetuses.
MATERIALS AND METHODS
Litters of nine crossbred gilts were studied. After an overnight fast, gilts at 70 d of gestation (315 of term) were premedicated with sodium thiopental and then prepared for surgery as described elsewhere (II). Gilts were maintained with halothane (fluothane) in oxygen and vital signs were recorded continuously during surgery and the postoperative period. An incision was made midventral, cranial to the pubic symph ysis, and the uterine horns exteriorized from the abdominal cavity. Subsequent surgical procedures are generally described elsewhere (12) . In short, fetal hypox was performed by electrocoagulation with a fine, insulated (except for the tip) cautery needle (12) . The fetus was palpated to the anti mesometrial surface of the uterus, where there are fewblood vessels and the amnion is fused to the chorion. A hole was made into the frontal bone of the fetus with an In a number of studies, we have shown that the development of fetal pig adipose tissue was markedly sensitive to genetically or experimentally induced alterations in the endocrine profile (for review see Refs. 1 and 2). For instance, fat cell size and lipogenic enzyme activity were greater in fetuses of genetically obese dams than in fetuses from lean dams (3). When examined 205 gauge needle and the cautery needle was placed in the hole and guided blindly to the floor of the cranium and into the pituitary fossa. The pituitary was then electrocoagulated for several seconds.
At this point, some of the hypox fetuses received T4 pellets (21-d release; Innovative Research of America, Toledo, OH) by first palpating the fetus to the anti mesometrial surface and making a small incision in the uterine wall. The uterine incision was raised to prevent loss of amniotic fluid. A small pocket was made in the lateral musculature of an exposed hind leg with a small, blunt hemostat for placement of a T4 pellet. It was not necessary to suture the fetal leg incision. A broad spectrum antibiotic was liberally applied around the fetus before closing the uterine incision (12) . Fetal membranes and the uterine wall were closed together with a continuous 5.0 silk suture preventing placental separation and conjoining of fetal and maternal circulations (12) . This was overlaid with a line of Lambert sutures. At 90 d of gestation (0/5 of term), midline laparotomies were performed on anesthetized dams and fetal blood samples drawn from the umbilical artery and fetuses were collected, dried, and weighed. Fetuses were examined in detail and individual organs (e.g. heart, liver, lungs, and kidneys) were removed, weighed, and closely examined. The completeness of the hypox was assessedby careful examination of the pituitary fossa for tissue remnants. Confirmation of hypox was also made by measurement of serum cortisol and LH concentrations.
Pellets were implanted exclusively in hypox fetuses in four litters. One to two groups of three fetuses consisting of a control, a hypox fetus, and a T 4-treated (15-mg pellet) hypox fetus were obtained from each of these four litters. In five additional litters, control (intact) and hypox fetuses were implanted with either 5-mg or 15-mg T 4 pellets. In three of these litters, all experimental fetuses survived, resulting in the following group of six fetuses: a control, a hypox fetus, a 5-mg and 15-mg-treated hypox fetus and a 5-mg and 15-mg-treated control. As a result of fetal death, the other two litters contained incomplete groups, with the collective loss of a 15-mg-treated control and a 5-mg-and 15-mg-treated hypox fetus. In two litters, untreated hypox fetuses were implanted with placebo pellets (15-mg size).
Histology and histochemistry. As detailed elsewhere (13), 2-to 3-mm wide blocks of dorsal-most subcutaneous tissue (including skin and adipose) from the shoulder were removed immediately and prepared for histologic and histochemic studies. One fourth of the tissue blocks were fixed in Bouin's fixative and routinely processed into paraffin blocks. The remaining blocks were snapfrozen in isopentane, cooled in liquid N 2 , and stored in an ultracold freezer. Details are given elsewhere for routine staining procedures for cryostat (-20T) sections of frozen tissue (14) and for sections of wax-embedded tissues (13) .
Immunocytochemistry and enzyme cytochemistry. (16) . After immuno-and/ or cytochemistry, cryostat sections were fixed for 10 min at room temperature in 4% paraformaldehyde, rinsed with PBS, and mounted in Elvanol (16a) .
Quantitative analysis of stained cryostat sections. Within individual sections, the percentage of the area either reactive for LPL and G6PDH or stained for lipid (oil red 0) was quantified by computer-assisted image analysis using aDage CCD-72 camera (Dage-MTl, Michigan City, IN) and IM-3000 software (Analytical Imaging Concepts, Irving, CA). Viewed at 35x magnification, the pixel size of the video screen was 5.3 x 4.3 /lm. Figure  I demonstrates the location and size of the area analyzed in the inner layer of adipose tissue. Gray values range between 0 (black) and 256 (white). Lipid-stained sections were analyzed at a thresh- old of 125, whereas G6PDH-and LPL-reacted sections were analyzed at a threshold of 55. Table I characterizes the image analysis in regard to the number and total area of thresholded objects (fat cell clusters). A similar number of fat cell clusters were thresholded within a treatment group for LPL-and G6PDH-reacted sections (Table I ). In lipid-stained sections, the number of fat cell clusters (thresholded objects) was similar for control and hypox fetuses, whereas the total cluster area and therefore the average cell cluster area were greater for hypox fetuses (Table 1) , which is consistent with morphologic observations (Fig. 2) . As planned, the total area (object area plus area not thresholded) analyzed per section was similar across treatment groups within a stain or enzyme reaction group. For instance, the total area analyzed per section for lipid-stained sections was (mean ± SEM; mm") '7.2 ± 0.17 (15 mg, hypox), 7.3 ± 0.24 (control), and 7.55 ± 0.26 (hypox). To evaluate the repeatability of this type of measurement, LPL-reacted sections from five pairs of hypox and control fetuses (five dams) were analyzed on two different days; total area analyzed and thresholded object area and number were not significantly influenced by day of analysis (p > 0.05).
The area in the outer layer (adipose tissue) depicted in Figure  1 was analyzed with respect to number of thresholded objects (fat cell cluster number). The number of fat cell clusters and the foci of blood vessels were counted in the outer layer of micrographs of antilaminin-stained sections from hypox, hypox + IS mg T 4 , and control fetuses (n = 3).
Fat cell sizes. Fat cell diameters were determined on sections of paraffin-embedded tissues according to Sjostrom et at. (17) . Twenty-five diameters were measured for each fetus in sections stained with the periodic acid-Schiff reagents (18) to demonstrate basal laminae. Only cells with a prominent basal lamina were measured.
Hormone assays. Blood was kept on ice for 4 h before centrifugation and harvesting serum.
Serum cortisol was measured using a coated tube RIA kit (Ventrex Laboratories, Inc., Portland, ME). The kit provides tracer, antibody-coated tubes, standards, and high and low pools. Samples were pipeted into coated tubes, cortisol tracer was added 206 HAUSMA N 'I",· . Sections from pa raffin-embedded blocks stai ned for con nective tissue with the picro pon ceau reagents (18) . Ori ginal magn ificat ion , x20.
R ESULTS
In all but six of the hypox fetuses, the ablation was judged to be complete. Mean corti sol concentrations were higher ( p < 0.05) in control (intact) fetuses than in hypox fetuses regardless of th yroxine treatment (Table 2) . Serum LH concentrations for 13 hypox fetuses were less than the assay sensitivity (0.22 Il.l/L), which contrasts with the mean (± SEM) LH concentration for 17 intact fetuses, i.e. 1.26 ± 0.24 lUlL. LH and cortisol values for hypox fetuses were similar in the present and another study (2 1), which supports the use of these parameters to confirm the visual appraisal ofhypox. Serum T4 concentrations were elevated ( p < 0.05) in S-mg and IS-mg Ta-treated hypox fetuses and in IS-mg Ta-treated intact fetuses when compared with T4 levels in their respective controls (Table 2) . Serum samples from four to five control, hypox, and l S-mg Ta-hypox fetuses were assayed for T 3 , but all values were below 0.47 nmol/L, which was the lowest level detectable by the assay. Serum samples from four control and four IS-mg T4 control fetuses were assayed for T 3 by Roch e was added and the samples were incubated for another 20 min at room temperature. The assay was centrifuged at 1500 x g for 10 min and the tub es were decanted before radioactivity was determ ined. Assay sensitivity was 9 pmol /L, The int raassay CV was 4.5 % and the interassay CV was 6.4%.
Statistics. Data were subjected to an analysis of varia nce procedure of the Statistical Analysis Systems (20) to determine the main effects of fetal condition (hypox versus control), treatment (T4) , and condition x treatment interactions. The main effect of dam or litter (all fetuses from one dam) per se could not be determined, because one group of fetuses (i.e . a hypox, control, hypox + T4, etc.) was obtai ned from seven of the nine dam s used. As a result, each fetus represented a separate dam (n = 6 fetuses = 6 dam s) for most measurements. Differences between means were determined by the least squares contrasts of the Statistical Analysis Systems pro cedure. decanted and radioactivity was determined. Assay sensitivity was 15 nmol/L, The intraassay CV was 9.31% and interassay CV was 7.01%. T4 concentrations were measured using a Ventrex coated tube RIA . The kit pro vides T4 antibody coated tubes , T4 125 1 tracer, assay buffer, and standards. Samples were pipet ed into coated tubes, tracer was added , and the assay was incubated for I h at 20-2YC. Tubes were inverted and radioactivity was determined. Sensitivity of the assay was 6.4 nmol/L, The intraassay CV was 3.5% and interassay CV was 3.3%.
Serum LH concentrations were determined using a double antibody assay routinely used and validated in this lab ( 19). Samples and standard curves were incubated in first antibod y (rabbit anti -bovine LH , developed by this lab) and 1% BSA for 24 h at 4°C. A second antibody (sheep anti-goat, anti-rabbit) and pol yethylene glycol were added to the assay tub es, which were vortcxed and centrifuged for 15 min at 3000 rpm (2100 x g) .
The supernatant was poured off and the inverted tubes were allowed to dry for several hours before radioactivity was determined. Assay sensitivity was 0.15 IVIL. Intraassay CV was 6.0% and the interassay CV was 10.2%.
Serum concentrations of insulin were determined with a double antibody RIA kit. Insulin tracer and antiserum, pools, standards, and precipitating reagent are provided in the kit. V nknowns were pipeted into 12 x 75 boros ilicate tubes. Insulin tracer and a ntiseru m were then added. The assay tubes were vortexed and incubated at room temperature for 90 min. Precipitating reagent * Least squares mean ± SEM for 10 to 11 fetuses each for the hypox-15 mg, control, and hypox groups, and three to five fetuses each for th e co ntro l-I 5 mg, control-5 mg, and hypox-5 mg groups. There was a significant main effect (p < 0.01) of T, treatm ent , but no effect of fetal co ndition (hypox vs control) on fat cell cluster numbers, hair follicle and hair shaft densit y, and subcutaneous th ickn ess. Main effects of T, treatment (p < 0 .001) and fetal condition were significant for T4 levels, whereas only fetal condition affected (p < 0.01) cortisol levels. There were no significa nt treatment x condition interactions for these param eters .
t Thi ckness measurements included th e outer and inner layers of adipose tissue, but excluded th e der mis and epide rm is. T he number of hair follicle and hair shaft profiles in skin cross-sectio ns (relative to th e long axis of th e body) were co unted .
t ' §' 11 Means within a row with differen t superscripts are different (p < 0.05).
Biovet (Burlington, NC) and values for two control fetuses and one Ta-treated fetus were below assay dete ctability of 0.31 nmol/ L. The mean ± SEM of T, values for the remaining fetuses were 0.44 ± 0.05 nmol /L for controls and 0.52 ± 0.11 nmol /L for T4 (15 mg)-treated controls. The refore , T 4 treatment did not significantl y elevate T 3 levels in hypox and intact (control) fetu ses. Insulin concentrations were not affected by hypox or T4 treatment and were (mean ± SEM, n = 6) 18 ± 0.72, 20 ± 3.2 and 21 ± 1.5 pmol/L for control, hypox, and 15 mg hypo x groups, respectively. H ypox fetuses had a typical appearance, i.e. edematous and hairless (4), whereas T4 treatment antagonized this edematous condition and was associated with a light hair coa t. Intact fetuses treated with 15 mg T4 were similar in appearance to Ta-treated hypox fetuses. Body weights and skin developm ent. T4 treatment of intact (controls) and hypox fetuses and hypox per se had no influence on body weight ( Table 2 ). The development of hair follicles and hair shafts was markedly enhanced by T4 treatment of intact and hypox fetuses (Fig. 2 and Table 2 ). A dose (T4)-dependent increase in hair follicle and shaft den sity was evident in intact fetuses (Table 2 ) and, as expected, untreated hypox fetuses had the lowest density of hair follicles and shafts ( Fig. 2 and Table  2 ). The depo sition of connective tissue in the dermis was also enhanced by T4 treatment of intact and hypox fetuses, resulting in greater demarcation of dermis from subcutaneous tissue (Fig.  2) . Thickness ofthe subcutaneous adipose tissue was significantl y reduced by 5-mg and 15-mg T4 treatment of hypox fetuses and by 15-mg T4 treatment of int act fetuses (Table 2) . Associated with the reduced tissue th ickness was a reduction in th e edematous condition and a greater condensation of connective tissu e fibers (data not shown).
M orphology and histochemistry ofthe middle layer ofadipose tissue. Treatment of hypox fetuses with 15 mg T4 significantly increased the size of fat cell clusters, whereas treatment of intact fetuses with this dose of T4 had no influence on fat cell cluster size (Fig. 3) . Accord ingly, image an alysis oflipid-stained sectio ns showed that the percentage of area occupied by fat cell clusters was not affected by T4 treatment except for a I-fold increase induced by the high dose of T, in hypox fetuses (Fig. 4) . Hyp ox p er se was associated with subtle changes in fat cell cluster morphology (Figs. 3 and 4) .
T4 treatment of intact fetuses had no influence on the percentage of tissue area (in sections) reactive for LPL and G6PDH enzymes (Fig. 4) . These percentages (LPL , G6PDH) were significantly increased by hypox and were increased even further by the combination of hypox and T4treatm ent (Fig. 4) . T4treatment mark edly enhanced the percentage of enz yme (LPL, G6PDH)-reactive fat cell clusters when compared with hypophysectomy alone (Fig. 4) . The extent of esterase reacti vity was greatest in sections from Ta-treated hypox fetuses and least (no ne) in section s from intact and Ta-treated ( 15 mg) intact fetus es (Fig. 5) .
Th e AGV shown in Table 1 are indi cative of the intensity of th e enzyme reaction; the lower th e AGV, the greater the enzyme reaction. Activity ofLPL (staining intensity) was enh an ced (lower AGV ) by hypox and increased furth er with the combination of T 4 treatment and hypox (Ta ble 1). Values (LPL-AGV) for 5-mg Ta-hypo x fetuses were (mean ± SEM) 34 ± 2.3 and values for 15-mg T4 intact fetuses were 46.8 ± 2.8. Therefore, T4 treatment of intact fetuses had no influence on LPL activity, where as 5-mg and 15-mg T4 treatment of hyp ox fetuses significantly increased LPL activity (Table 1) . Activity of G6PDH (AGV) was enhanced by hypox, but T4 treatment of intact (data not shown) and hypox fetuses had no influence on G6PDH activity (Table 1) .
Fat cell size and morph ology. T 4 treatment of intact fetuses had no influence on fat cell size, i.e. fat cell diameters-least squares means ± SEM for four fetuses: for controls, 14.4 ± 0.3; and for controls with 15-mg T4 pellets, 14.1 ± 0.4. Treatment of hypox fetuses with T4 resulted in a slight increase ( p < 0.05) in fat cell size, i.e. cell diam eters-least squares mean ± SEM for six fetuses: for hypox, 2 1.6 ± 0.75; hypox with 5 mg T 4 , 24.5 ± 0.93; and hypox with 15 mg T4, 24.5 ± 0.75. Fat cell size was significantly incre ased by hypox (see above and Fig. 6 ). Fat cells in hypox and Ta-treated and untreated intact fetuses typically had many lipid droplets (multilocular), whereas fat cells in 15-mg Ta-treated hypox fetuses were predominantly uni locular (one lipid droplet), despite th e similarity in cell size for hypox and T 4 (15 mg)-treated hypox fetu ses (Fig. 6) . In 5-mg T4-treated hypox fetu ses, the number of un ilocular cells was less than that for 15-rng-treated hypox fetuses, but mu ch more than that for untreated hypox fetuses (data not shown).
M orphology ofthe outer layer ofadipose tissue. Image analysis of the outer layers in lipid-stained sections showed that fat cell cluster (threshold objects) number was not influenced by hypox or by T4 treatment, except for the high T4 dose in hypo x fetuses ( Table 2 ). The number of fat cell clusters and blood vessel foci in the outer layers of sections stained for laminin (antilaminin) were (mean ± SEM; n = 3) 28.5 ± 1.3, 30 ± 1.7, and 28 ± 1.6/ mm ? for hypox, Ta-treated (15 mg) hypo x, and intact fetus es, respectively. These values were not significantly different from each other ( p < 0.05 ). 
DISCUSSION
The results presented herein clearly show that experimentally elevated levels of serum T4 were associated with distinct morphologic changes in skin and subcutaneous tissue of hypox and intact porcine fetuses. For instance, skin and hair development was markedly stimulated and the myxedema of the subcutaneous tissue (thickness) was reversed by T4 treatment. These effects are typical for T4 (22) , whereas the unexpected and remarkable aspect of the present study was that T4 did not, by any measure, influence adipose tissue development in intact fetuses, but profoundly enhanced adipose tissue development in hypox fetuses. One explanation of this apparent discrepancy is that a pituitaryderived or pituitary-dependent hormone effectively antagonized the adipogenic potential of T4 in intact fetuses. Consideration of relevant in vivo (3) (4) (5) and in vitro (6, 8) results suggests that on may be the antagonistic hormone. For instance, low GH levels and elevated T4 levels were associated with enhanced adipose tissue development in two fetal models (3, 5) . Furthermore, numerous studies of growing swine show that daily injections of GH markedly reduce carcass fat deposition and enhance lean deposition (for review see Ref. 23 ). Porcine and rat preadipocyte development in vitro is also antagonized by GH and enhanced by T4 (6) (7) (8) , and hypox per se enhances the adipogenic potential of fetal pig serum on preadipocyte cultures (6) . Therefore, the data in the present study coupled with supporting evidence indicate that GH may antagonize the adipogenic potential of T, in the fetal pig. However, there is a preponderance of evidence from studies of preadipocyte cell lines indicating that GH enhances adipogenesis at the cellular and molecular level (for review see Ref. 24) . More definitive studies of GH in vivo are needed to resolve the issue of GH and adipogenesis.
The dicotomy of the fetal adipose tissue response to T 4 treatment could also be explained by consideration of potential involvement oflipogenic substrates and hormones. For instance, hypox per se could elevate insulin levels as observed in a previous study (25) and T4 treatment of hypox fetuses could elevate insulin levels further, as well as enhance cortisol secretion at the level of the adrenal gland (26) . However, insulin levels were not affected by hypox (with and without T4 treatment) and cortisol levels were not affected by T4 treatment in the present study. However, insulin levels in the current study may be artifactually low because fetuses need to be chronically catheterized to properly evaluate fetal pig insulin levels (27) . Therefore, the serum insulin status in the present study is not clear and the possible association of serum insulin and T4 with adipose tissue development in the fetus is in need of more study. IGF-I levels were significantly (28) . However, IGF-I is ineffective in cultures of fetal pig cells (29) , despite having a positive affect on preadipocyte development in cultures of cells from young pigs (7, 30) . Therefore, elevated IGF-I levels may not account for the augmented adipose cell development in T 4-treated hypox fetuses. And finally, serum glucose and triglyceride levels were not elevated in Ta-treated hypox fetuses (Hausman DB, unpublished observations), which suggests that these metabolites were also not associated with adipose cell development in Ta-treated hypox fetuses.
This study is the first to demonstrate an effect of T 4 on the cellular development of fetal adipose tissue. Specifically, T4 slightly increased fat cell size, but markedly enhanced fat cell cluster hypertrophy and lipogenic enzyme activity in hypox fetuses. Fat cell size was independent of T, dose (hypox fetuses), but only the largest T4dose (15 mg) induced a significant increase in fat cell cluster growth (percentage of area, lipid-stained sections). This fat cell cluster growth cannot be accounted for by an increase in fat cell size and therefore had to be associated with an apparent increase in fat cell number. Although this is indirect evidence, it does demonstrate, for the first time, that preadipocyte recruitment and/or replication as well as differentiation was enhanced by T 4 in the fetus. These results are consistent with results of in vitro studies in which T4 supplementation of serum from hypox fetuses enhanced the capacity of serum to stimulate preadipocyte replication and differentiation (6) . Therefore, in vitroand in vivo data suggest that T4plays a primary role in fetal preadipocyte recruitment and/or replication and differentiation.
Consideration of the various adipose tissue responses in hypox fetuses indicates that only LPL activity responded to T4treatment in a dose-dependent manner. For instance, the extent of LPL staining (percentage of area) in hypox fetuses was greatest with 15 mg T4, lowest with no T4, and intermediate with 5 mg T4 treatments. Furthermore, the intensity of LPL staining (AGV) was enhanced by the low T4dose (5 mg), which slightly increased fat cell size but did not affect fat cell cluster growth (percentage of area, lipid staining). In a relevant study, a large increase in LPL activity in adipose tissue from preobese fetuses was also associated with minimal changes in adipose tissue cellularity (3). LPL hydrolyzes blood-borne triglycerides and lipids into fatty acids for assimilation into tissue lipids (31) . Therefore, blood levels of LPL substrates (lipids, etc.) are an important consideration, because LPL activity may simply reflect substrate levels (31) . In fact, blood triglyceride levels were positively associated with adipose tissue LPL levels in preobese fetuses (3, 32) , whereas LPL levels were not associated with substrate levels in the present study (no treatment effect on lipid levels). Furthermore, levels of lipogenic hormones, i.e. insulin and cortisol, were not elevated by T4treatment and, therefore, not associated with elevated LPL levels in the present study. Therefore, T4 may directly induce LPL activity during adipocyte differentiation in hypox fetuses. However, the involvement ofIGF-I as an endocrine or autocrine/ paracrine modulator ofLPL cannot be eliminated. Nevertheless, the Ta-treated hypox fetus is a suitable model to examine induction of LPL during adipocyte differentiation.
Fat cell clusters were reduced in number in the outer layer of adipose tissue of hypox (d 70) fetuses when examined at 110 d of gestation (4) . In the present study, however, hypox did not reduce fat cell cluster number (outer layer), but fetuses were examined 20 dafter hypox as opposed to 40 d in the previous study (4) . Therefore, the effect of hypox on fat cell number is dependent upon the length of exposure to hypox. Nevertheless, the l5-mg T4 treatment induced greater fat cell cluster numbers in the outer layer of hypox fetuses (present study). This elevated cluster number (15 mg T4) could be an artifact of the counting procedure associated with the reduced subcutaneous thickness. However, the tissue thickness was reduced similarly in 5-mg and 15-mg T4-treated hypox fetuses, but cell cluster numbers were not increased by the 5-mg T4 treatment. Therefore, the high T4 dose increased fat cell numbers in the inner and outer layers of tissue in hypox fetuses. Additionally, there was a trend (p < 0.09) for higher cell cluster numbers in 15-mg Ta-treated compared with untreated intact fetuses. Thus, T 4 may dictate, in part, the hyperplastic growth of fetal adipose tissue. Definitive studies of the mechanism of action of T4 are needed to fully establish the physiologic significance of these findings.
